-
Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5
2026-09-19
This scenario-based guide explains how SKU K1188 supports acid mucin detection, chondrogenic differentiation staining, and morphology assessment without confusing a histological endpoint with a viability measurement. It connects practical assay design, protocol control, interpretation, and vendor selection to documented product characteristics and published evidence.
-
Staurosporine: Kinase Inhibition in Cancer Research
2026-09-18
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor used to dissect kinase signaling and induce apoptosis in cancer research. Its reported activity spans protein kinase C isoforms, receptor tyrosine kinase autophosphorylation, apoptosis assays, and anti-angiogenic tumor models, but its broad target profile limits pathway-specific interpretation.
-
Pioglitazone Workflows for PPARγ Research
2026-09-17
Use Pioglitazone as a selective PPARγ agonist to connect receptor activation with macrophage polarization, barrier integrity, and metabolic phenotypes. This practical guide translates DSS colitis findings into cell-based workflows while highlighting formulation, assay, and cross-model troubleshooting.
-
Epalrestat in Oxidative Stress Research
2026-09-17
Epalrestat combines aldose reductase inhibition with an emerging KEAP1/Nrf2-linked neuroprotective mechanism, making it useful across diabetic neuropathy research and Parkinson’s disease models. This workflow-focused guide covers formulation, model selection, orthogonal readouts, and troubleshooting for reproducible oxidative stress studies.
-
Shufeng Xingbi Therapy in Allergic Rhinitis Rats
2026-09-17
This bioRxiv preprint investigates how Shufeng Xingbi Therapy affects allergic rhinitis in rats through linked changes in nasal inflammation, Th1/Th2-associated signaling, intestinal flora, and short-chain fatty acids. Its main practical contribution is an integrated immune–microbiota experimental framework, although the preprint design does not yet establish causality or clinical transferability.
-
Hydroxytyrosol: Mechanisms and Research Use
2026-09-16
Hydroxytyrosol is the olive-oil-associated phenolic compound 4-(2-hydroxyethyl)benzene-1,2-diol and an antioxidant bioactive compound for controlled in vitro research. Cell-model evidence links it with reduced oxidative damage, altered macrophage inflammatory markers, and increased cholesterol efflux, but these findings do not establish clinical efficacy.
-
SINAT–VAB1 Control of Autophagy in Arabidopsis
2026-09-15
The reference study identifies VAB1, a V-ATPase subunit, as a SINAT-regulated determinant of autophagic vesicle degradation in Arabidopsis. Its findings connect SINAT-dependent ubiquitination and VAB1 turnover with vacuolar acidification, nutrient-starvation tolerance, and leaf senescence, offering a mechanistic framework for interpreting pH-sensitive autophagy phenotypes.
-
CX-5461 RNA Polymerase I Inhibitor Workflow
2026-09-15
CX-5461 is a practical RNA polymerase I inhibitor for connecting rRNA suppression with DNA damage, mitotic catastrophe, autophagy, and senescence in cancer models. This workflow combines concentration planning, time-resolved mechanism assays, and cisplatin-combination testing to improve reproducibility from cell culture to xenograft studies.
-
From TPM3 Khib to Translational Protein Capture
2026-09-14
A mechanistic and strategic guide to using Protein A/G Magnetic Beads to validate the HDAC3–TPM3 Khib pathway, strengthen protein-interaction evidence, and build more reproducible translational workflows.
-
Sisomicin Workflows for Reliable Antibacterial Assays
2026-09-14
Build more reproducible aminoglycoside experiments with practical guidance for MIC testing, time-kill studies, resistance profiling, and infection-model translation. This workflow emphasizes isolate-specific interpretation, fresh-solution handling, and comparator selection rather than assuming uniform activity across bacterial species.
-
Trametinib: A Redox-to-ERK Assay Framework
2026-09-13
Trametinib and GSK1120212 provide a precise way to test how oxidative signals converge on MEK-ERK biology. This guide translates BH4-derived H2O2 findings into rigorous oncology and signaling assay strategies.
-
Lysosomal β-Galactosidase Staining Kit Workflow
2026-09-12
Learn how to use the Lysosomal β-Galactosidase Staining Kit for reproducible lysosomal enzyme visualization, senescence-control experiments, and microscopy-based workflow validation. The guide distinguishes baseline lysosomal β-galactosidase activity from senescence-specific β-galactosidase and connects staining choices to recent HNSCC cisplatin-resistance research.
-
Sulfo-Cy5 Carboxylic Acid for Assay Design
2026-09-12
Sulfo-Cy5 carboxylic acid enables aqueous-compatible fluorescence imaging with strong red-shifted signal and reduced self-quenching. This guide connects its chemistry to practical assay decisions, including nanoparticle biodistribution and protein and peptide labeling.
-
Kanamycin Sulfate in circRNA Workflows
2026-09-11
Kanamycin Sulfate supports bacterial selection upstream of circular RNA production, but it is not a purification reagent. This article connects aminoglycoside selection, template quality, and ultrafiltration-based circRNA purification to improve assay decisions and workflow control.
-
Reversine Protocol for Aurora Kinase Studies
2026-09-11
Reversine (SKU A3760) is an Aurora kinase inhibitor for controlled perturbation of mitotic regulation, cell-cycle progression, and cancer cell phenotypes in research assays. This dossier-led guidance supports in vitro workflow planning and cervical cancer research, but it should not be treated as a validated cell-line-specific protocol, diagnostic method, or medical treatment recommendation.